Position in PCRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$41,256,322
-$7,501,623 QoQ
Shares Held
1,825,501
-3.1% QoQ
Ownership
4.64%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,196,847,717 across 49 Drug Manufacturers - Specialty & Generic names. PCRX ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,787,019 | $1,059,666,526 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,418,897 | $318,665,490 | |
| 3 | ALKS |
Alkermes plc.
|
6,160,428 | $217,832,734 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,859,728 | $108,857,232 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,705,222 | $88,142,925 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,989,100 | $55,358,132 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,469,449 | $48,594,678 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
2,118,080 | $43,971,340 |
All Filings in PCRX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,256,322 | 1,825,501 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $48,757,945 | 1,884,001 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $55,101,439 | 2,138,201 | Shares | Sole | 2025-11-13 | |
| 2025-07-01 | $49,713,173 | 2,138,201 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $57,254,863 | 2,395,601 | Shares | Sole | 2025-08-13 | |
| 2025-04-08 | $62,932,438 | 2,395,601 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $55,678,934 | 2,240,601 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $37,540,602 | 1,992,601 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $29,783,904 | 1,978,997 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $59,113,896 | 2,066,197 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $54,997,796 | 1,882,197 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $57,921,356 | 1,716,697 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $49,517,427 | 1,613,997 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $63,098,108 | 1,574,697 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $63,618,586 | 1,558,897 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $61,277,815 | 1,587,097 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $93,268,505 | 1,753,497 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $114,588,475 | 1,965,497 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $142,031,291 | 1,860,997 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $111,266,183 | 1,849,197 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $110,252,632 | 1,968,797 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $125,020,642 | 2,060,327 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $162,244,121 | 2,314,797 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $157,083,530 | 2,625,059 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $167,139,431 | 2,780,097 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $149,581,318 | 2,850,797 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $82,756,801 | 2,468,142 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||